INTRINSIC SYMPATHOMIMETIC ACTIVITY OF PENBUTOLOL

被引:49
作者
NYBERG, G
WILHELMSSON, C
VEDIN, A
机构
[1] Section of Preventive Cardiology, Department of Medicine, Östra Hospital, Göteborg
关键词
alprenolol; beta-blockade; intrinsic sympathomimetic activity; penbutolol; propranolol;
D O I
10.1007/BF00568197
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Six healthy volunteers took part in a randomized, single-blind, crossover study to quantitate the intrinsic sympathomimetic activity (ISA) of penbutolol in comparison with one drug possessing ISA (alprenolol) and with the standard non-ISA drug (propranolol). Single intravenous and one week oral administrations were studied. Complete parasympathetic and sympathetic isolation of the heart was obtained by administration of atropine 0.04 mg/kg body weight i. v. and propranolol 0.4 mg/kg i. v., or corresponding equipotent doses of alprenolol 0.4 mg/kg i. v. and penbutolol i. v. 0.08 mg/kg. In the chronic, oral study propranolol 160 mg b. i. d. was given, or corresponding equipotent doses of alprenolol (400 mg b. i. d.) or penbutolol (40 mg b. i. d.). The test procedure included measurement of heart rate and blood pressure in the supine, sitting and standing positions, and during isometric and dynamic exercise. ISA was calculated by comparison of the change in of heart rate with that produced by propranolol. The ISA of alprenolol was 22-26% and of penbutolol 12-18% of maximal sympathetic activity. Isometric and dynamic exercise gave comparable ISA values. © 1979 Springer-Verlag.
引用
收藏
页码:381 / 386
页数:6
相关论文
共 18 条
  • [1] PHARMACOLOGICAL STUDIES OF 2 NEW CARDIOSELECTIVE ADRENERGIC BETA-RECEPTOR ANTAGONISTS
    ABLAD, B
    CARLSSON, E
    EK, L
    [J]. LIFE SCIENCE PART 1 PHYSIOLOGY & PHARMACOLOGY, 1973, 12 (03): : 107 - 119
  • [2] COMBINED PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES ON ALPRENOLOL AND 4-HYDROXY-ALPRENOLOL IN MAN
    ABLAD, B
    BORG, KO
    JOHNSSON, G
    REGARDH, CG
    SOLVELL, L
    [J]. LIFE SCIENCES, 1974, 14 (04) : 693 - 704
  • [3] ALAD B, 1967, ACTA PHARMACOL TO S2, V25, P85
  • [4] ALAD B, 1967, ACTA PHARMACOL TO S2, V25, P9
  • [5] INTRINSIC HEART-RATE ON EXERCISE AND MEASUREMENT OF BETA-ADRENOCEPTOR BLOCKADE
    CARRUTHERS, SG
    SHANKS, RG
    MCDEVITT, DG
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (06) : 991 - 999
  • [6] ANTAGONISM BY PROPRANOLOL AND ALPHA-METHYLPROPRANOLOL (ICI-77602) OF VASCULAR AND CARDIAC RESPONSES TO ISOPRENALINE IN ANESTHETIZED DOGS
    FITZ GERALD, JD
    ODONNELL, SR
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1978, 5 (06) : 579 - 586
  • [7] GUIDICELLI JF, 1977, BRIT J CLIN PHARMACO, V4, P135
  • [8] HANSON L, 1973, ACTA MED SCAND S, V550, P1
  • [9] HARTFELD.G, 1972, ARZNEI-FORSCHUNG, V22, P930
  • [10] JOHNSSON G, 1967, ACTA PHARMACOL TOX, VS 25, P95